4:00 PM – 7:30 PM

Registration Open

Exhibit & Poster Set-Up

6:00 pm – 7:30 pm

Welcome Reception

Join us for the Welcome Reception at the Cheyenne Mountain Resort Grand Rivers Terrace and launch into the fabulous 2025 WAGO Annual Meeting! You’ll be basking in breathtaking mountain views and soaking up the beauty of the majestic Rocky Mountains!

WAGO is grateful for our commercial support for the Welcome Reception:

6:30 AM – 8:00 AM

Breakfast, Poster Presentations, Exhibit Hours

6:30 PM – 12:00 PM

Registration Open

8:00 AM – 8:10 AM

Welcome & Opening Remarks

8:10 AM -9:15 AM

General Session 1: Beyond the Tumor: Patient Factors Shaping Outcomes

8:10 am – 8:25 am
Frailty, disability, and quality of life in older adults with gynecologic cancer – interim data from the PROmOting gynecologic cancer patients to achieve Functional recovery (PROOF) cohort study, Presented by Stephanie Cham, MD, MS, UCSF

8:26 am – 8:41 am
Prevalence of Ovarian Cancer Cachexia in Patients Undergoing Debulking Surgery at the University of Colorado between 2014-2024, Presented by Eseohi Ehimiaghe,MD, University of Colorado Anschutz Medical Campus

8:42 am – 8:57 am
Application of the patient generated subjective global assessment for nutritional risk in patients with gynecologic malignancies, Presented by Nicole Minalt, MD University of Oklahoma Health Sciences Center

8:58 am – 9:13 am
Application of the patient generated subjective global assessment for nutritional risk in patients with gynecologic malignancies, Presented by Nicole Minalt, MD University of Oklahoma Health Sciences Center

9:14 am – 9:29 am
Racial and ethnic disparities in frequency and time to hospice referral among patients with recurrent cervical cancer, Presented by Brittany File,MD, University of California Irvine

9:30 am – 9:45 am
Pre-operative cross-sectional imaging of chest, abdomen, pelvis is not cost-effective for low-grade endometrial cancer, Presented by Isabel Beshar,MD, Phil,Stanford Healthcare

9:45 AM – 10:00 AM

Break

10:00 AM – 11:03 AM

General Session 2:

10 am – 10:15 am
The Correlation Between Increasing Incidence of Uterine, Colorectal, and Breast Cancer Among Young Female Patients in the United States, Presented by Natalie Ayoub,MD, University of California Irvine

10:16 am – 10:31 am
Is AI Your Next Genetic Counselor for Patients with Gynecologic Malignancy? Presented by Mia Ramirez, BSA, McGovern Medical School 

10:32 am – 10:47 am
Ovarian Cancer in Patients with Pathogenic Variants over 70 years old: Real-World Data Informing Screening and Risk Reduction in Older Age, Presented by Eliya Shachar, MD, University of California Los Angeles

10:48 am – 11:03 am
What do we have to lose? An evaluation of NIH funding for gynecologic cancers, Presented by Lily Zello, Clinical Trials Analyst,University of Califoria Los Angeles

11:05 am – 11:20 am 
Mountains to Climb: Gynecologic Cancer Research in an Uncertain Funding Landscape, Presented by Benjamin Bitler, PhD; Associate Professor; D. Thomas and Kay L. Dunton Endowed Chair in Ovarian Cancer Research; The University of Colorado Anschutz Medical Campus

11:20 AM – 12:20 PM

Presidential Lecture:
Well-Being and Resilience: Navigating our Neurobiological Response in Times of Uncertainty

Presented by: 
Dr. Anne Browning
Chief Well-Being Officer, UW Medicine
Associate Dean for Well-Being, University of Washington School of Medicine

12:05 PM – 1:50 PM

Industry Supported Symposium:
A Treatment Option for Patients With Primary Advanced or Recurrent Endometrial Cancer

Presented by:
Lyndsay J. Willmott, MD, FACOG 
Director of Gynecologic Research, Arizona Center for Cancer Care (Honor Health)
Director of Gynecologic Oncology, Banner University Medical Center in Phoenix, Arizona

Click here for more information on this symposium.

2:05 pm

Speaker Rehearsal, Tumor Board Rehearsal

4:40 PM

Busses Depart for Whirlyball
Meet at the Lobby of the Cheyenne Mountain Resort

5:30 PM – 7:00 PM

Networking Event

6:30 AM – 8:00 AM

Breakfast, Poster Presentations, Exhibit Hours

6:30 AM – 12:00 PM

Registration Open

7:00 AM – 8:00 AM

Trainee & Early-Career Faculty Session

7:00 AM – 8:00 AM

WAGO Business Meeting

8:15 AM – 9:20 AM

General Session 3

8:15 AM – 9:35 AM

8:15 am – 8:30 am
Assessment of the Performance of Cervical Cancer Screening Methods in Transmasculine Patients, Presented by Katherine Bolten, MD, Oregon Health and Science University

8:31 am – 8:46 am
High-risk, low-resource: overcoming barriers to cervical cancer prevention, Presented by Julie Sammouri, MD, UTHealth McGovern Medical School

8:47 am – 9:02 am
Human Papillomavirus (HPV) Vaccination Rates within a Large National Network of Community Health Organizations: A Cross-Sectional Study, Presented by Amanda Bruegl, MD, Oregon Health & Science University

9:03 am – 9:18 am
Implementation of primary HPV-based cervical cancer screening across a countywide health system, Presented by Patrick Marta, MD, Harbor-UCLA Medical Center, Olive View-UCLA Medical Center

9:19 am – 9:34 am
Postpartum HPV vaccination is a cost-effective strategy for prevention of cervical dysplasia and cancer, Presented by Christine Nguyen, MD, Oregon Health and Sciences University

9:35 AM – 9:50 AM

Break

9:50 AM – 10:37 AM

General Session 4: To Checkpoint & Beyond: Novel Targets in Gynecologic Cancer Care

9:50 am – 10:05 am 
Treatment Outcomes with Ipilimumab and Nivolumab Combination in Recurrent Neuroendocrine Cervical Cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study, Presented by Alissa Chebat, MD, MD Anderson Cancer Center

10:06 am – 10:21 am
Ovarian cancer proteomic biomarkers for pembrolizumab response, Presented by Katherine Kleinberg,DO, Vanderbilt University Medical Center

10:22 am – 10:37 am
Novel LIFR-targeted combination therapy to enhance the utility of standard-of-care chemotherapy in treating ovarian cancer, Presented by Sonal Chaudhari, MD, University of Texas Health Sciences Center at San Antonio

10:40 AM – 11:40 AM

Tumor Board

11:55 AM – 1:25 PM

Industry Supported Symposium:

Beyond ADCs: Exploring Novel Therapeutic Opportunities in Platinum Resistant Ovarian Cancer

Presented by:

Click here for more information.

6:00 PM – 8:00 PM

President’s Reception

Join us at the President’s Reception for an evening of celebration at the Garden of The Gods Resort amidst the breathtaking views of the stunning red rock sandstone formations, set against the backdrop of Pikes Peak. This remarkable venue offers a serene and captivating atmosphere, untouched and tranquil, surrounded by awe-inspiring natural beauty.

WAGO is grateful for our commercial support for the President’s Reception:

6:30 AM – 8:00 AM

Breakfast, Poster Presentations, Exhibit Hours

6:30 AM – 12:00 PM

Registration Open

6:30 AM – 8:00 AM

Poster Presentations & Exhibit Hall Open

7:00 AM – 8:30 AM

ASCO Update

8:30 AM – 9:49 AM

General Session 5

8:30 am – 8:45 am
Palliative care needs in outpatients with advanced gynecologic malignancies: Bridging the gap in advance care planning, Presented by Valeria Melo, MD, UCSF

8:46 am – 9:01 am
Survivorship sexual health after pelvic radiation for cervical cancer, Presented by Megan Ryu, UC Irvine School of Medicine

9:02 am – 9:17 am
CAPRICORN: community activated partnership for research in improving cervical cancer outcomes, a resource and navigation pilot study, Presented by Leah Wormack, MD MS, University of California San Francisco

9:18 am – 9:33 am
Percutaneous nephrostomies in gynecologic malignancy can be a pain in the back, Presented by Julia Ritchie,MD, Loma Linda University Hospital

9:34 am – 9:39 am
Coping with cancer: a trilingual graphic medicine approach to women’s oncology, Presented by Alexandra Bartholomew, Medical Student,Louisiana State University Health Sciences Center School of Medicine – New Orleans

9:50 AM – 10:05 AM

Break

10:05 AM – 11:24 AM

General Session 6

10:05 am – 10:20 am
Finding the balance between effective and durable pain control in the perioperative setting., Presented by Karina Gomez,MD, PhD, University of California Los Angeles

10:21 am – 10:36 am
Ten Years of Double-Barrel Wet Colostomy: A Single Institution’s Experience Performing an Alternative Diversion in Patients Undergoing Total Pelvic Exenteration for Gynecologic Malignancy, Presented by Andrew Tannous,MD, Saint Joseph Hospital Denver Colorado

10:37 am – 10:52 am
The effectiveness of low-pressure pneumoperitoneum on post-operative pain in gynecologic oncology surgery, Presented by Allison Walker,MD, St. Luke’s University Health Network

10:53 am – 11:08 am
Surgical site infection rate based on surgical prophylaxis in hysterectomy patients in a multi-hospital health system, Presented by Angela Conway,MD, MS, Ochsner Clinic Foundation

11:09 am – 11:24 am
Robotic Management of Extrauterine Endometrial Stromal Sarcoma in Paraaortic Lymph Nodes: A Rare Case with Unusual Imaging and Surgical Challenges, Presented by Evrim Erdemoglu,Clinical Research Fellow, Department of Medical and Gynecological Surgery, Mayo Clinic, Arizona

11:25 AM – 11:30 AM

Closing Remarks & WAGO 2026 Annual Meeting Location Announcement

2025 Poster Presentations

Poster #1: Drivers of delay and treatment prolongation in locally advanced cervical cancer
Presented by: Joyce Wang, MD, University of Washington

Poster #2: Treatment Patterns and Outcomes in Cervical Gastric-Type Adenocarcinoma
Presented by: Matthew Wong, The University of Texas Health Science Center

Poster #3: Clinicopathologic characteristics and survival outcomes in women with endometrial neuroendocrine tumors
Presented by: Matthew Wong, The University of Texas Health Science Center

Poster #4: Outcomes of Advanced Stage Endometrial Cancer by Residual Disease and MMR Status
Presented by: Katherine Jane Chua, MD, University of California Davis Health System

Poster #5: Diabetes mellitus mortality amongst endometrial cancer patients: Analysis of the SEER database
Presented by: Kyra Hunsberger, The University of Arizona College of Medicine – Phoenix

Poster #6:

Poster #7:

Poster #8:

Poster #9:

Poster #10:

Poster #11:

Poster #12:

Poster #13:

Poster #14:

Poster #15:

Poster #16:

Poster #17:

Poster #18:

Poster #19:

Poster #20:

Poster #21:

Poster #22:

Poster #23:

Poster #24:

Poster #25:

Poster #26:

Poster #27:

Poster #28:

Poster #29:

Poster #30:

Poster #31:

Poster #32:

Poster #33:

Poster #34:

Poster #35:

Presented by: Matthew Wong, The University of Texas Health Science Center

WAGO 2026 Annual Meeting

Wednesday, June 17 –  Saturday, 20, 2026

2024 WAGO Annual Meeting

Wednesday, June 12 – Saturday, June 15

Seattle, Washington

Fairmont Olympic Hotel Seattle

Click here for a pdf of the 2024 WAGO Annual Meeting Schedule of Events.

2024 Poster Presentations

Poster #1

Understanding the Role of at-risk cytology and co-testing categories in cervical cancer development: are current tactics in management sufficient?

Presenting Author: Caroline Doyle, BS

Poster #2

Clinical characteristics of patients with cervical cancer undergoing fertility-sparing surgery with cervical excision and lymph node evaluation

Presenting Author: Ashley Zhang, BS

Poster #3

Predicting final pathologic diagnosis by cervical excision margins and endocervical curettage

Presenting Author: Ryan Woodson, MD

Poster #4

Survival in HPV and non-HPV associated invasive cervical cancer: outcomes in a large, integrated healthcare system

Presenting Author: Gracie Williams, MD

Poster #5

The relationship between history of sexual assault and cervical cancer: A meta-analysis

Presenting Author: Kyra Hunsberger, BA

Poster #6

Characterization of Patients with Recurrent and Persistent Cervical Cancer after Chemoradiation Therapy: A Retrospective Chart Review

Presenting Author: Lauren Quinto, MD

Poster #7

Association of Time to Surgery and Rates of Endometrial Cancer in Patients with Endometrial Intraepithelial Neoplasia

Presenting Author: Justin Kim, MD

Poster #8

The Clinical Course of Atypical Polypoid Adenomyoma: A Rare Lesion of Ovulatory Dysfunction

Presenting Author: Susan Lang, MD

Poster #9

Surgical complications with and without removal of the uterus during proctectomy following pelvic radiation for colorectal malignancy

Presenting Author: Roshni Ray, MD

Poster #10

Rate of homologous recombination repair gene expression in endometrial cancer patients

Presenting Author: Alexandra Smick, MD

Poster #11

Long-term survival outcomes of robotic-assisted versus traditional laparoscopy for the treatment of stage I endometrial cancer: a National Cancer Database analysis

Presenting Author: Sarah Davidson, MD

Poster #12

Clinical outcomes in non-English-speaking women undergoing cervical cancer treatment

Presenting Author: Laura Potter, BA

Poster #13

Sociodemographic Factors Associated with Distress among a Diverse Gynecologic Oncology Patient Population

Presenting Author: Joe Haydamous, MD

Poster #14

Influence of genetic risk awareness on high grade serous fallopian tube carcinoma diagnoses

Presenting Author: Christine Walsh, MD, MS

Poster #15

A Comparative Study of Ovarian Cancer Family History by Germline Genetic Testing Results

Presenting Author: Rebecca Shin, MD

Poster #16

Incorporation of immunotherapy or biological targeted therapy in primary anti-cancer treatment in gynecologic malignancy

Presenting Author: Matthew Lee, MD

Poster #17

The Utility of a Gastrointestinal Workup in Patients Diagnosed with Borderline and Invasive Ovarian Mucinous Neoplasms

Presenting Author: Lauren Tostrud, MD

Poster #18

Real-world outcomes of neoadjuvant chemotherapy for ovarian cancer: What happens to patients who never undergo surgery?

Presenting Author: Kelly Bruce, MD

Poster #19

Mucinous ovarian neoplasm – Outcomes of a rare tumor

Presenting Author: Bahareh Hamedi, MD

Poster #20

Establishing a platform for investigating poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitor sensitivity in PARP1 knockout cells

Presenting Author: Lindsey Nguy, MD

Poster #21

Pathologic staging discrepancies between stage I and II ovarian and tubal high grade serous carcinoma (HGSC) and impact on survival.

Presenting Author: Kayla Sompel, BS

Poster #22

Non-serous fallopian tube carcinoma: a case series

Presenting Author: Joyce Wang, MD

Poster #23

Cancer care navigation, access to care, and adherence to guideline-based cervical cancer treatment across the 2nd largest US public healthcare system

Presenting Author: Alexandra Smick, MD

Poster #24

Implementation of a Cancer Care Navigation Program in Gynecologic Oncology patients within Safety-net Hospitals

Presenting Author: Daisy Cruz, MD

Poster #25

Non-cancer related emergency department utilization in newly diagnosed endometrial cancer patients

Presenting Author: Chrissy Liu, MD

Poster #26

Let’s talk about sex: Sexual wellbeing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer survivors

Presenting Author: Luis Felipe Falla Zuniga, MD

Poster #27

Palliative care referral and utilization at time of diagnosis in patients with recurrent or advanced stage gynecologic cancers at a single institution

Presenting Author: Breana Hill, MD

Poster #28

Lack of association of routine depression screening results with patient reported needs assessment.

Presenting Author: Alexandra Smick, MD

Poster #29

Outpatient specialty palliative care referral patterns among gynecologic cancer patients

Presenting Author: Rubina Ratnaparkhi, MD

Poster #30

In vitro characterization of patient-derived samples demonstrates the heterogeneity of high grade serous ovarian cancer

Presenting Author: Julia Ritchie, MD

Poster #31

In vitro low passage patient-derived cells demonstrate lack of faithfulness to original sample

Presenting Author: Julia Ritchie, MD

Poster #32

Simplification of Molecular Diagnostics for Point-of-Care HPV Screening

Presenting Author: Jill Roberts, MD

Poster #33

Tumor size predicts overall survival in uterine carcinosarcoma

Presenting Author: Hannah Beer, MD

Poster #34

Characterization and Length of Hospice Admission in Patients with Recurrent Cervical Cancer: A Retrospective Chart Review

Presenting Author: Nicole Spencer, MD

Poster #35

Provider Acceptability of a Biopsy-First Approach to Diagnosis of Endometrial Cancer

Presenting Author: Maya Gross, MD, MPH

Poster #36

Spatial RNA sequencing supports programmed death ligand 2 (PD-L2) as a potential immunotherapy target in high grade serous ovarian carcinoma (HGSOC)

Presenting Author: Elise Yates, MD